हिंदी में पढ़ें
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
Aurobindo Pharma News
JPMorgan on Aurobindo Pharma stock re-rating trigger and target price
Thu, Apr 22, 2021
In its report, JPMorgan says that the injectables business of Aurobindo Pharma includes the $1.4bn U.S. franchise (likely the best profitability among peers), EUR700+Mn European operation (largest EU player from India), RoW and an API business. Even assuming a generics business multiple of 8-9x, Aurobindo Pharma's business could be valued at Rs 1,400 - 1,500/share. This does not capture the upside from its complex pipeline investment (respiratory, biosimilar or API growth from PLI scheme)
Stock Of The Day: Anil Singhvi reveals his top recommendation for investors today - Aurobindo Pharma
Thu, Apr 08, 2021
Aurobindo Pharma share price today: Zee Business Managing Editor Anil Singhvi has said today that Pharma shares will remain in focus going forward. Singhvi said that from next week the results season will start
Aurobindo Pharma share price: Sharekhan retains Buy recommendation with price target of Rs 1100
Wed, Mar 31, 2021
Aurobindo Pharma’s US business is expected to stage a marked improvement. A mix of factors, which includes a sturdy pipeline of new products, expected traction in the lucrative injectables space driven by strong new product pipeline and commissioning of a new facility coupled with growth in the recently launched products would boost US business’ sales
SBI, Ashok Leyland, ACC, IRCTC, Aurobindo Pharma: Technical Analysis for traders in top stocks
Wed, Mar 31, 2021
Ashis Biswas, Head of Technical Research at CapitalVia Global Research has revealed trading strategies in SBI, Ashok Leyland, ACC, IRCTC and Aurobindo Pharma. Ashis has highlighted the reason for the trade and also mentioned the stop-loss in these counters.
Aurobindo Pharma Share price: Sharekhan retains their Buy recommendation with a revised Price target of Rs 1100
Fri, Feb 12, 2021
Aurobindo Pharma Q3 FY21 revenue, operating profits and PAT were a tad below the estimates. Sales at Rs 6365 cr is up 8% yoy (slightly below estimates), attributable to an 11.3% yoy growth in the formulations segment, while API sales were down 13.6% yoy. OPM expanded by 100 BPS yoy to 21.5% (estimated OPM 22%) led by a 310 bps expansion in gross margins, which were partly offset by an increase in other expenses.
Aurobindo Pharma, Biocon, Dr Reddy’s Lab and Divi’s Laboratories: Resilient demand points to another good year for Pharma Sector says HSBC
Thu, Jan 21, 2021
After four difficult years, the India pharma sector rallied in 2020, and HSBC expects the benign operating environment to lead to another good year. HSBC revised their estimates and target prices, and rolled forward our valuations to December 2022e from September 2022e. HSBC also preview Q3 FY21e results, where they expect the recovery to continue for most of the companies that HSBC covers.
Nifty to Sensex - All you need to know about markets today
Wed, Nov 25, 2020
Banking and financial stocks dragged the most while IT and pharma stocks also weighed on the indices. The Sensex declined by 1.6% or 695 points to 43828. The Nifty plunged by 1.5% or 197 points to 12858. The Nifty sees its biggest 1-day fall in nearly 5 months.
Key Covid-19 vaccines India banking on-Oxford/AstraZeneca, Novavax | Credit Suisse highlights Aurobindo Pharma, Apollo Hospitals stocks
Wed, Nov 11, 2020
India needs about 1.7 bn COVID-19 vaccine doses to vaccinate the majority of its adult population. It targets to administer 400-500 mn doses by July 2021. The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax and J&J (temperature range is 2-8°C) and the earliest efficacy data is expected by end of Nov 2020/Dec 2020 and in the best case, vaccines can be rolled out in Jan 2021.
Stock Market Today: Sensex, Nifty dip after range-bound intraday trade; Bharti Airtel, Aurobindo Pharma shares bleed
Thu, Aug 13, 2020
Stock Market Today: The BSE Sensex lost 59 points and closed at 38,310 mark while the NSE Nifty went down 7 points and closed at 11,300 levels. Bank Nifty index went down 67 points and closed at 22,196 mark.
Aurobindo Pharma share price: Most early gains given up, but still closes over 1 pct higher
Fri, Jun 05, 2020
Aurobindo Pharma share price: Shares of Aurobindo Pharma on Thursday gave up most of their early gains on profit-booking and closed over 1 per cent higher.
Stocks in Focus on June 4: BPCL, HDFC Life to Pharma Companies; here are expected newsmakers of the day
Thu, Jun 04, 2020
Stocks in Focus on June 4: BPCL, HDFC Life, Aurobindo Pharma, Sun Pharma, etc. are expected to remain newsmakers throughout the intraday trade session.
Why Aurobindo Pharma-Sandoz deal fell apart? Check brokers' reactions
Fri, Apr 03, 2020
Hyderabad-based Aurobindo Pharma's decision to break its deal with Sandoz will likely impact the company and its stocks according to analysts who track the sector. The biggest reason why this decision has been taken is due to the company not getting approval from US Federal Trade Commission (FTC)
Cipla share price plunges nearly 6 pct after USFDA issues warning letter for Goa facility
Wed, Feb 26, 2020
Cipla tumbled nearly 6 per cent after the US health regulator issued a warning letter for its Goa manufacturing facility.
Sensex, Nifty rise ahead of US-China trade deal; NALCO, Hero MotoCorp, Aurobindo Pharma stocks gain
Tue, Jan 14, 2020
The stock market of Indian trade range-bound ahead of the much-awaited US-China trade deal scheduled on 15th January 2020. The BSE Sensex rose 92 points and closed at 41,952 levels while the 50-stocks Nifty went up 32 points and closed at 12,362 levels.
Sensex, Nifty slip on sixth straight trade session; Aurobindo Pharma, DHFL, Ashok Leyland stocks bleed
Mon, Oct 07, 2019
The stock market of India sinks on sixth straight trade session. The BSE Sensex lost 141 points and closed at 37,531 levels while the 50-stock Nifty went down 48 points and closed at 11,126 level after the closing bell trade session.
Sensex soars over 600 points, Nifty climbs 11K, Bank Nifty scales 28K; Aurobindo Pharma, Vodafone Idea stocks gain
Thu, Aug 08, 2019
The BSE Sensex shot up 636 points and closed at 37,327 levels while the Nifty-50 index scaled 11,000 levels after gaining 176 points today. The Bank Nifty index shot up 408 points and closed above 28,00 levels at 28,110 levels.
Sensex, Nifty find comfort in Chinese trade data, yuan fix; Aurobindo Pharma, Yes Bank stocks gain
Thu, Aug 08, 2019
The BSE Sensex opened 175 point sup at 36,866 levels while the 50-stock Nifty opened 58 points higher at 10,913 levels. the Bank Nifty index was 117 points up at 27,819 levels.
Stocks in Focus on July 11: Infra stocks, DHFL to Ajmera Realty; here are the 5 Newsmakers of the Day
Thu, Jul 11, 2019
There are certain stocks that came in news after the market was closed on Wednesday and can play a pivotal role on Thursday intraday trade.
Aurobindo Pharma completes $300 mn deal to acquire 7 oncology products from US-based firm.
Sat, Mar 02, 2019
According to the definitive agreements inked between the two companies, Acrotech Biopharma LLC, a subsidiary of Aurobindo, will pay an upfront purchase price of USD 160 million in cash plus up to USD 140 million on achieving regulatory and sales-based milestones for the seven products.
Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018
Mon, Dec 31, 2018
The sector has been volatile throughout the year due to constant news flow in the markets. Some giants of the sector witnessed objections over their manufacturing plants and medicine pricing in the U.S. markets.